Ketodan Tablet contains Alpha Ketoanalogue (NA), a specialized nutritional supplement primarily used in the management of chronic kidney disease (CKD). It serves as a nitrogen-free analogue of essential amino acids, designed to provide the necessary substrates for protein synthesis while minimizing nitrogenous waste production, thereby reducing the burden on impaired renal function. Ketodan is typically prescribed as an adjunct to a low-protein diet in patients with moderate to severe CKD to delay the progression of renal failure and reduce uremic symptoms. The tablet facilitates the maintenance of nutritional status by supplying ketoanalogues that are transaminated to essential amino acids in the body, supporting muscle preservation and overall metabolic balance. Its use requires careful monitoring by healthcare professionals to ensure appropriate dietary protein restriction and to prevent potential complications such as hyperkalemia or metabolic imbalances. Ketodan is contraindicated in patients with hypersensitivity to its components and should be used cautiously in those with severe hepatic impairment. Regular assessment of renal function, electrolyte levels, and nutritional status is recommended during therapy. Ketodan Tablet is a valuable component in the multidisciplinary approach to CKD management, aimed at improving patient outcomes and quality of life.